|
|
Article: Cantel Medical's Crosstex Subsidiary Launches New Specially Treated Face Mask Effective Against H1N1 Influenza
- Article from:
- U.S. Newswire
- Article date:
- October 13, 2009
CopyrightCopyright 2009 U.S. Newswire. Provided by ProQuest LLC. (Hide copyright information)
|
To: MEDICAL EDITORS
Contact: Andrew A. Krakauer, President and CEO of Cantel Medical
Corp. , +1-973-890-7220; or Richard E. Moyer of Cameron Associates,
Inc., +1-212-554-5466, richard@cameronassoc.com
LITTLE FALLS, N.J., Oct. 13 /PRNewswire-FirstCall/ -- CANTEL
MEDICAL CORP.(NYSE: CMN), through its Crosstex International
subsidiary, has launched a unique face mask treated with
BIOSAFE((R))antimicrobial in markets outside the United States.
Crosstex' new BIOSAFE-treated Ultra Sensitive face masks begin to
reduce microorganisms, such as MRSA, VRE and Staph, immediately upon
contact. These treated face masks have proven to be effective
against Influenza A strains, such as seasonal flu and the ...